Gary Volkell
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,724 | 121 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $896.30 | 30 | $0 (2024) |
| Biogen, Inc. | $720.79 | 25 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $341.40 | 7 | $0 (2024) |
| Acorda Therapeutics, Inc | $274.57 | 4 | $0 (2023) |
| Allergan, Inc. | $164.18 | 4 | $0 (2021) |
| ACADIA Pharmaceuticals Inc | $156.03 | 5 | $0 (2024) |
| REVANCE THERAPEUTICS, INC. | $119.19 | 3 | $0 (2024) |
| Medtronic, Inc. | $82.56 | 2 | $0 (2024) |
| Lilly USA, LLC | $82.40 | 4 | $0 (2024) |
| Amneal Pharmaceuticals LLC | $80.07 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,570 | 42 | ABBVIE INC. ($410.79) |
| 2023 | $551.17 | 21 | AbbVie Inc. ($272.71) |
| 2022 | $990.48 | 47 | Biogen, Inc. ($285.40) |
| 2021 | $240.10 | 7 | Biogen, Inc. ($141.26) |
| 2020 | $113.22 | 1 | Allergan, Inc. ($113.22) |
| 2019 | $258.82 | 3 | Acorda Therapeutics, Inc ($258.82) |
All Payment Transactions
121 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: NEUROLOGY | ||||||
| 12/11/2024 | Biogen, Inc. | AVONEX (Biological), TYSABRI, VUMERITY | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Neurology | ||||||
| 11/25/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $31.90 | General |
| Category: Neurology | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $32.69 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/19/2024 | Biogen, Inc. | AVONEX (Biological), TYSABRI, VUMERITY | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: Neurology | ||||||
| 10/23/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $108.71 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: Neuroscience | ||||||
| 10/21/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $54.19 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 10/14/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: NEUROLOGY | ||||||
| 10/10/2024 | Amneal Pharmaceuticals LLC | — | Food and Beverage | In-kind items and services | $28.41 | General |
| 10/07/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $66.43 | General |
| Category: AMANTADINE | ||||||
| 10/03/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Neurology | ||||||
| 09/29/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $121.77 | General |
| Category: Neuropsychiatry | ||||||
| 09/28/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $35.13 | General |
| Category: Neurology | ||||||
| 09/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $132.21 | General |
| Category: Neuropsychiatry | ||||||
| 09/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $57.96 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 09/06/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $34.37 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/27/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $32.13 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $34.25 | General |
| Category: Neurology | ||||||
| 07/24/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $104.77 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 07/16/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Immunology | ||||||
| 07/09/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $32.50 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 601 | 11,901 | $521,344 | $168,860 |
| 2022 | 10 | 560 | 7,986 | $390,384 | $143,024 |
| 2021 | 4 | 293 | 349 | $108,249 | $40,322 |
| 2020 | 1 | 11 | 13 | $4,104 | $1,148 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 24 | 11,050 | $153,153 | $54,570 | 35.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 225 | 369 | $145,387 | $51,172 | 35.2% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 91 | 106 | $73,140 | $22,621 | 30.9% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 20 | 53 | $37,209 | $9,574 | 25.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 61 | 61 | $31,603 | $8,515 | 26.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 34 | 35 | $17,010 | $4,965 | 29.2% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 23 | 58 | $12,610 | $3,927 | 31.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 37 | $10,432 | $3,557 | 34.1% |
| 64646 | Injection of chemical for paralysis of nerve muscles on trunk, 1-5 muscles | Office | 2023 | 19 | 47 | $21,703 | $3,388 | 15.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 23 | $6,305 | $2,323 | 36.9% |
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 13 | 13 | $5,393 | $1,497 | 27.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 19 | 20 | $4,025 | $1,431 | 35.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 21 | 29 | $3,374 | $1,319 | 39.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 258 | 414 | $146,142 | $60,315 | 41.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 20 | 7,260 | $100,624 | $35,211 | 35.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 160 | 160 | $80,480 | $28,135 | 35.0% |
| 99483 | Assessment of and care planning for impaired thought processing, typically 50 minutes | Office | 2022 | 26 | 27 | $18,630 | $6,474 | 34.8% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 11 | 21 | $14,130 | $3,686 | 26.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 12 | 12 | $5,772 | $1,909 | 33.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 17 | $4,583 | $1,886 | 41.2% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2022 | 15 | 25 | $5,025 | $1,803 | 35.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 18 | $4,500 | $1,570 | 34.9% |
| 64646 | Injection of chemical for paralysis of nerve muscles on trunk, 1-5 muscles | Office | 2022 | 11 | 18 | $8,946 | $1,353 | 15.1% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 12 | 14 | $1,552 | $682.71 | 44.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 83 | 96 | $33,888 | $14,875 | 43.9% |
About Gary Volkell
Gary Volkell is a Student in an Organized Health Care Education/Training Program healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2016. The National Provider Identifier (NPI) number assigned to this provider is 1679937338.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Gary Volkell has received a total of $3,724 in payments from pharmaceutical and medical device companies, with $1,570 received in 2024. These payments were reported across 121 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,724).
As a Medicare-enrolled provider, Volkell has provided services to 1,465 Medicare beneficiaries, totaling 20,249 services with total Medicare billing of $353,354. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Neurology
- Location Albany, NY
- Active Since 04/08/2016
- Last Updated 08/31/2020
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1679937338
Products in Payments
- QULIPTA (Drug) $501.57
- VUMERITY (Drug) $479.63
- UBRELVY (Drug) $333.83
- INBRIJA (Drug) $274.57
- INGREZZA (Drug) $267.35
- NUPLAZID (Drug) $156.03
- TYSABRI (Biological) $143.34
- DAXXIFY (Drug) $119.19
- TEFLARO (Drug) $113.22
- BOTOX (Biological) $111.86
- AVONEX (Biological) $97.82
- PERCEPT PC BRAINSENSE (Device) $82.56
- Gocovri (Drug) $66.43
- Leqembi (Drug) $66.15
- KYNMOBI (Drug) $63.78
- AUSTEDO (Drug) $58.09
- Ongentys (Drug) $52.30
- BAFIERTAM (Drug) $50.19
- UPLIZNA (Drug) $49.70
- Ponvory (Drug) $48.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Albany
Anuj Malhotra, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $224,738
Dr. Erica Parrotta, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $111,723
William Raible, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $42,671
Dr. Olumayowa Abiodun, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $33,199
Dr. Alexandra Paul, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $15,462
Dr. Sridhar Musuku, M.d Frca, M.D FRCA
Student in an Organized Health Care Education/Training Program — Payments: $14,736